Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2023 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean simajiri m (1 results)?
Correction: A novel therapeutic effect of mannitol-rich extract from the brown seaweed Sargassum ilicifolium using in vitro and in vivo models.
Premarathna AD, Tuvikene R, Somasiri M, De Silva M, Adhikari R, Ranahewa TH, Wijesundara R, Wijesekera SK, Dissanayake I, Wangchuk P, Rjabovs V, Jayasooriya AP, Rajapakse R. Premarathna AD, et al. Among authors: somasiri m. BMC Complement Med Ther. 2023 Feb 15;23(1):50. doi: 10.1186/s12906-023-03879-z. BMC Complement Med Ther. 2023. PMID: 36793028 Free PMC article. No abstract available.
A novel therapeutic effect of mannitol-rich extract from the brown seaweed Sargassum ilicifolium using in vitro and in vivo models.
Premarathna AD, Tuvikene R, Somasiri M, De Silva M, Adhikari R, Ranahewa TH, Wijesundara R, Wijesekera SK, Dissanayake I, Wangchuk P, Rjabovs V, Jayasooriya AP, Rajapakse R. Premarathna AD, et al. Among authors: somasiri m. BMC Complement Med Ther. 2023 Jan 31;23(1):26. doi: 10.1186/s12906-023-03840-0. BMC Complement Med Ther. 2023. PMID: 36721189 Free PMC article.
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial.
Gnanenthiran SR, Wang N, Di Tanna GL, Salam A, Webster R, de Silva HA, Guggilla R, Jan S, Maulik PK, Naik N, Selak V, Thom S, Prabhakaran D, Schutte AE, Patel A, Rodgers A; TRIUMPH Study Group. Gnanenthiran SR, et al. JAMA Cardiol. 2022 Jun 1;7(6):645-650. doi: 10.1001/jamacardio.2022.0471. JAMA Cardiol. 2022. PMID: 35416909 Free PMC article. Clinical Trial.